# Revent's Investments in United States: 15 Startups by Sector (2026)

> The 15 startups in the United States that Revent has backed, by sector: Biotech, Pharma and AI and more. $186M raised. Updated nightly.

Source: https://millionrounds.com/portfolio-maps/revent-2-investments-united-states (Millionrounds; every figure on the page links to its filing or article)

## Biotech

11

- [OncoNano Medicine](https://millionrounds.com/company/onconano-medicine)
- [*CB* CrossBridge Bio](https://millionrounds.com/company/crossbridge-bio)
- [ImmunoGenesis](https://millionrounds.com/company/immunogenesis)
- [Dialectic Therapeutics](https://millionrounds.com/company/dialectic-therapeutics)
- [Barricade Therapeutics](https://millionrounds.com/company/barricade-therapeutics)
- [ImmuneSensor Therapeutics](https://millionrounds.com/company/immunesensor-therapeutics)
- [Diakonos Oncology](https://millionrounds.com/company/diakonos-oncology)
- [Salarius Pharmaceuticals](https://millionrounds.com/company/salarius-pharmaceuticals)
- [Emtora Biosciences](https://millionrounds.com/company/emtora-biosciences)
- [dfusion](https://millionrounds.com/company/dfusion)
- [Instadiagnostics](https://millionrounds.com/company/instadiagnostics)

## Pharma

2

- [Indapta Therapeutics](https://millionrounds.com/company/indapta-therapeutics)
- [Allterum Therapeutics](https://millionrounds.com/company/allterum-therapeutics)

## AI

2

- [ScienceMachine](https://millionrounds.com/company/sciencemachine)
- [InformAI](https://millionrounds.com/company/informai)

## Segment by segment

### Biotech

11 startups · $129M raised

- [**OncoNano Medicine**](https://millionrounds.com/company/onconano-medicine) OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease. United States $28M
- [*CB* **CrossBridge Bio**](https://millionrounds.com/company/crossbridge-bio) CrossBridge Bio operates as a biotechnology company. United States $25M
- [**ImmunoGenesis**](https://millionrounds.com/company/immunogenesis) ImmunoGenesis specializes in science-driven immune therapies for tumor treatment. United States $17M
- [**Dialectic Therapeutics**](https://millionrounds.com/company/dialectic-therapeutics) Dialectic Therapeutics is a biotechnology company focused on creating innovative new technologies to end cancer. United States $14M
- [**Barricade Therapeutics**](https://millionrounds.com/company/barricade-therapeutics) Barricade Therapeutics is a privately held biotech company. United States $14M
- [**ImmuneSensor Therapeutics**](https://millionrounds.com/company/immunesensor-therapeutics) ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other diseases. United States $10M
- [**Diakonos Oncology**](https://millionrounds.com/company/diakonos-oncology) Diakonos Oncology is a clinical-stage immuno-oncology company based in Houston, Texas, founded in 2016. United States $7.0M
- [**Salarius Pharmaceuticals**](https://millionrounds.com/company/salarius-pharmaceuticals) Salarius Pharmaceuticals is an oncology-based biotechnology company developing new therapies to address gene dysregulation. United States $7.0M

### Pharma

2 startups · $52M raised

- [**Indapta Therapeutics**](https://millionrounds.com/company/indapta-therapeutics) Indapta Therapeutics is a privately held biotechnology company. United States $51M
- [**Allterum Therapeutics**](https://millionrounds.com/company/allterum-therapeutics) Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers. United States $1.0M

### AI

2 startups · $5.0M raised

- [**ScienceMachine**](https://millionrounds.com/company/sciencemachine) ScienceMachine is a biotechnology research startup founded in 2024, based in London, UK, with additional operations in San Francis United States $3.5M
- [**InformAI**](https://millionrounds.com/company/informai) InformAI delivers AI-enabled clinical solution focused on oncology and diagnostic imaging to improve patient outcomes. United States $1.5M

**How this map is made.** Every startup here has raised money in a round we track that names Revent as an investor and is based in United States. Each sits under its main sector, read from its rounds, and each shows its best-funded first. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Portfolio map **Revent portfolio map** 28 startups · $335M](https://millionrounds.com/portfolio-maps/revent-2-portfolio-map)[Sector portfolio **Revent's Biotech portfolio** 11 startups · $97M](https://millionrounds.com/portfolio-maps/revent-2-biotech-portfolio)[Investments abroad **Global Founders Capital's investments in the United States** 64 startups · $2.0B](https://millionrounds.com/portfolio-maps/global-founders-capital-investments-united-states)[Investments abroad **NAP's investments in the United States** 40 startups · $712M](https://millionrounds.com/portfolio-maps/nap-investments-united-states)[Investments abroad **468 Capital's investments in the United States** 35 startups · $1.0B](https://millionrounds.com/portfolio-maps/468-capital-investments-united-states)[Investments abroad **Angel Invest's investments in the United States** 31 startups · $65M](https://millionrounds.com/portfolio-maps/angel-invest-investments-united-states)

## Raising from investors like Revent?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
